Amrutanjan Health Care Profit & Loss Annual

BSE: 590006 | NSE: AMRUTANJAN | ISIN: INE098F01031 | Sector: Biotechnology & Drugs

494.45 +2.60 (0.53%)Updated : 14 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	442.04	400.14	375.24	340.25
Other Net	17.57	1.66	1.32	2.49
Diluted Weighted Average Shares	2.89	2.89	2.90	2.92
Depreciation/ Amortization	6.32	6.53	6.06	5.21
Operating Income	60.51	51.67	45.99	39.39
Net Income	57.92	50.83	44.97	39.83
Income Availableto Com Excl Extra Ord	57.92	50.83	44.97	39.83
Other Operating Expenses Total	58.71	43.26	43.22	40.51
Net Income Before Taxes	77.89	69.13	61.95	53.65
Net Income After Taxes	57.92	50.83	44.97	39.83
Income Availableto Com Incl Extra Ord	57.92	50.83	44.97	39.83
Costof Revenue Total	244.36	226.72	215.67	185.04
Gross Profit	258.19	225.09	205.56	194.60
Interest Inc( Exp) Net- Non- Op Total	-0.20	15.80	14.58	11.74
Unusual Expense( Income)	8.86	0.20	0.65	-
Diluted Net Income	57.92	50.83	44.97	39.83
DPS- Common Stock Primary Issue	4.90	3.60	4.60	4.60
Provisionfor Income Taxes	19.97	18.30	16.97	13.81
period Type	-	-	-	-
Net Income Before Extra Items	57.92	50.83	44.97	39.83
Total Revenue	502.55	451.82	421.23	379.64
period Length	12.00	12.00	12.00	12.00
Revenue	502.55	451.82	421.23	379.64
Selling/ General/ Admin Expenses Total	123.80	123.43	109.65	109.49
Diluted Normalized EPS	22.31	17.63	15.65	13.62
Diluted EPS Excluding Extra Ord Items	20.03	17.58	15.50	13.63
Gain( Loss)on Saleof Assets	-	-	0.05	0.03